July 28 is World Hepatitis Day, an opportunity to raise awareness about viral hepatitis and its consequences. This year's theme is "4000 Voices," reflecting the estimated 4000 people who die from viral hepatitis -- primarily hepatitis B and C -- each day, out of the approximately 400 million thought to be infected worldwide.
The world faces an opportunity to expand antiretroviral therapy to all who need it -- both to improve the health of individuals living with HIV and to prevent transmission of the virus -- and treatment would likely be cost-effective, experts agreed at a press briefing at the 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention last week in Vancouver.
HIVandHepatitis.com coverage of the International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015), July 19-22, in Vancouver, Canada.
Conference highlights include HIV treatment as prevention, pre-exposure prophylaxis (PrEP), new antiretroviral therapies, HIV cure research, hepatitis C and HIV/HCV coinfection, and global scale-up of prevention and treatment.
A program at San Francisco General Hospital (SFGH) that offers antiretroviral therapy (ART) on the same day as HIV diagnosis led to a high rate of treatment uptake and more rapid viral load suppression than standard practices, according to late-breaking study findings presented at the 8th International AIDS Society Conference this week in Vancouver. Newly diagnosed people with HIV and clinic providers both expressed enthusiasm about the RAPID program, which is now being implemented more widely as part of the city's Getting to Zero initiative.